BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9045919)

  • 1. NFE, a new transcriptional activator that facilitates p50 and c-Rel-dependent IgH 3' enhancer activity.
    Linderson Y; Cross D; Neurath MF; Pettersson S
    Eur J Immunol; 1997 Feb; 27(2):468-75. PubMed ID: 9045919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element.
    Goto M; Katayama KI; Shirakawa F; Tanaka I
    Cytokine; 1999 Jan; 11(1):16-28. PubMed ID: 10080875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages.
    Kuprash DV; Udalova IA; Turetskaya RL; Rice NR; Nedospasov SA
    Oncogene; 1995 Jul; 11(1):97-106. PubMed ID: 7624137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
    Cogswell PC; Scheinman RI; Baldwin AS
    J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
    Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
    Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of IL-2 receptor alpha-chain gene by individual members of the rel oncogene family in association with serum response factor.
    Pierce JW; Jamieson CA; Ross JL; Sen R
    J Immunol; 1995 Aug; 155(4):1972-80. PubMed ID: 7636248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells.
    Berland R; Wortis HH
    J Immunol; 1998 Jul; 161(1):277-85. PubMed ID: 9647234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
    Schaffer A; Cerutti A; Shah S; Zan H; Casali P
    J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.
    Xu X; Gélinas C
    Oncogene; 1997 Apr; 14(13):1521-30. PubMed ID: 9129142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential nuclear expression of enhancer A DNA-binding proteins in human first trimester trophoblast cells.
    Boucraut J; Hawley S; Robertson K; Bernard D; Loke YW; Le Bouteiller P
    J Immunol; 1993 May; 150(9):3882-94. PubMed ID: 8473737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4+ T cells.
    Ouyang YL; Li S; Pestka JJ
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):328-36. PubMed ID: 8887449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
    Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
    J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
    Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
    Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    Sepulveda MA; Emelyanov AV; Birshtein BK
    J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.